Habitual Abortion
7
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
43%
3 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Intravenous Immunoglobulin and Prednisolone for RPL After ART.
Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction
Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages
Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL)
CXCL9 and CXCL11 Levels in Patients With Autoimmune Thyroiditis and Habitual Abortions
Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion
Use of G-CSF for the Treatment of Unexplained Recurrent Miscarriage